Home | Back to newsletter main page

Bookmark and Share
Case Comprehensive Cancer Center Newsletter

June 10, 2013

CASE CCC IN THE NEWS

Tivozanib for Kidney Cancer Rejected by FDA
Medscape - Jun 11, 2013
At the ODAC meeting, 1 of the committee members Mikkael Sekeres MD, MS, associate professor of medicine at the Cleveland Clinic Taussig Cancer Institute, in Ohio, said it would be difficult to explain these results to a patient.

Cleveland Cancer Researchers Host Policy Forum on Genomics and Cancer Treatment
The Plain Dealer - Jun 10, 2013
More than 200 people - oncologists and researchers from 17 universities and cancer centers in 13 states, patient advocacy groups, pharmaceutical and biotechnology company representatives - are in Cleveland today for a day-long dialogue on genomics and its impact on the diagnosis and treatment of cancer..."We have the ability to fingerprint each person's cancer at many points along the way, so we can target a treatment specifically for that person's tumor, so it's much more precise and much more exact," said Dr. Stanton Gerson, director of Case Comprehensive Cancer Center, which includes the Cleveland Clinic Taussig Cancer Institute and University Hospitals Seidman Cancer Center.

Bright Pink Cleveland Reaches Out to Young Women at High Risk for Hereditary Breast and Ovarian Cancer
The Plain Dealer - Jun 10, 2013
"We can bring everything together in one place," said Dr. Robert Shenk, medical director of the Breast Center at UH Case Medical Center and associate professor of surgery at Case Western Reserve University School of Medicine, who oversees the new center.

ASCO 2013 Myelodysplastic Syndromes Update - Day Three: Education Session
MDS Beacon - Jun 5, 2013
Dr. Mikkael Sekeres from the Cleveland Clinic gave the final talk of the education session. He spoke about the diagnosis and treatment of patients with MDS / myeloproliferative neoplasm (MPN) overlap disorders, such as chronic myelomonocytic leukemia (CMML), atypical chronic myeloid leukemia (CML), and refractory anemia with ring sideroblasts - thrombocytosis (RARS-T).

Analysis: New Cancer Breakthroughs Add Pressure to Control Costs
Yahoo Health - Jun 4, 2013
Insurers "are paying more attention to the appropriate use of interventions - there are more pre-reviews and less flexibility in 'off-label' use," said Dr. Neal Meropol, chief of the division of hematology and oncology at University Hospitals Case Medical Center in Cleveland. He was referring to the practice of prescribing drugs for uses not specifically approved by regulators.

Fine-Tuning Breast Cancer Treatments: What Works Better?
US News & World Report - Jun 3, 2013
Two common schedules used for the chemotherapy paclitaxel (Taxol) are equally effective at controlling breast cancer, but fewer side effects are found with the weekly regimen rather than every two weeks, according to a new study...The estimated five-year progression-free survival rates were the same for both groups, said Dr. G. Thomas Budd, who led the study.


ANNOUNCEMENTS

Dr. DiFeo Receives Funding from Mary Kay Foundation

difeoDr. Analisa DiFeo recently received funding from the Mary Kay Foundation for her project, Single Agent Dual Inhibition of the AKT and ERK Signaling Pathway for the Treatment of Ovarian Cancer.

EVENTS

calendar

June 10

 


June 11

 


June 12

Hematology and Oncology Division Research Conference
Erica Campagnaro, MD
Assistant Professor, Div. of Hem/Onc
CWRU/UH
Topic: Improving Outcomes in the Elderly Myeloma Patient
8 am Lerner B-151


June 13

Guest Lecturer
Jose Cancelas-Perez, MD, PhD
Professor, Pediatrics
University of Cincinnati
Deputy Director and Division Director of Research, Hoxworth Blood Center
Cincinnati Children's Hospital Medical Center
Topic: Intercellular Signaling Crosstalk in the Bone Marrow Stem Cell Niche
12 pm WRB 5-136


June 14

Taussig Cancer Institute Grand Rounds
Manish Shah, MD
Associate Professor, Medicine
Director, Gastrointestinal Oncology
Cornell University
Topic: Moving Towards Personalized Care for the Management of Advanced Gastric Cancer
8 am R3/002-003 Cleveland Clinic

Hematology and Oncology Fellows Conference
Topic: TBD
8 am Wearn 137/Breen Conference Rm.

Cancer Center Research in Progress
Duncan Stearns, MD
Assistant Professor, Pediatrics Hem/Onc
CWRU/UH
Topic: Tumor Derived COL3A1 Expression is Important For Growth In Medulloblastoma
4 pm WRB 3-136

 

 

Case CCC Calendar

LRI Calendar


UPCOMING CANCER CENTER SYMPOSIUMS & EVENTS

Annual Cancer Center Scientific Retreat
July 11-12

 

ADDITIONAL UPCOMING SEMINARS & EVENTS

National GvHD Health Symposium
November 1


PREVIOUSLY ANNOUNCED OPPORTUNITIES

OCRP Ovarian Cancer Academy Award - Early-Career Investigator
Pre-Application Deadline: June 12
Application Deadline: August 28

OCRP Ovarian Cancer Research Program Pilot Award
Pre-Application Deadline: June 12
Application Deadline: August 28

OCRP Ovarian Cancer Research Program Teal Innovator Award
Pre-Application Deadline: June 12
Application Deadline: August 28

James S. McDonnell Foundation Postdoctoral Fellowship Award in Studying Complex Systems
Deadline: June 14

Request for Proposals for Pilot Collaborations with LMICs in Global Cancer Research or Global Health Research at NCI-Designated Cancer Centers
Deadline: June 14

Limited Submission: Hartwell Foundation – Individual Biomedical Research Awards
Internal Deadline: June 17
Internal Application Deadline: July 19
External Deadline: September 16

BCRP Postdoctoral Fellowship Award
Pre-Application Deadline: June 18
Application Deadline: July 2

BCRP Era of Hope Scholar Award
Pre-Application Deadline: June 18
Application Deadline: July 2

PCRP Biomarker Development Award
Pre-Application Deadline: June 19
Application Deadline: October 9

PCRP Idea Development Award
Pre-Application Deadline: June 19
Application Deadline: October 9

PCRP Laboratory–Clinical Transition Award
Pre-Application Deadline: June 19
Application Deadline: October 9

PCRP Synergistic Idea Development Award
Pre-Application Deadline: June 19
Application Deadline: October 9

PCRP Transformative Impact Award
Pre-Application Deadline: June 19
Application Deadline: October 9

LCRP Idea Development Award
Pre-Application Deadline: June 20
Application Deadline: October 16

LCRP Career Development Award
Pre-Application Deadline: June 20
Application Deadline: October 16

Alex's Lemonade Stand Foundation Bridge Grants
Deadline: June 21

Alex's Lemonade Stand Foundation Springboard Grant
Deadline: June 21

OCRP Clinical Translational Leverage Award
Pre-Application Deadline: June 21
Application Deadline: September 11

OCRP Resource Development Award
Pre-Application Deadline: June 21
Application Deadline: September 11

BCRP Innovator Award
Pre-Application Deadline: June 25
Application Deadline: September 25

BCRP Breakthrough Award
Pre-Application Deadline: June 25
Application Deadline: September 25

St. Baldrick's Foundation Fall 2013 Infrastructure Grants
LOI Deadline: July 2

James Ewing Foundation of the Society of Surgical Oncology 2013 Fall Clinical Investigator Award in Breast Cancer Research
Deadline: July 8

LCRP Clinical Exploration Award
Pre-Application Deadline: July 9
Application Deadline: October 16

Case CCC Funding for Pilot/Phase I Clinical Trials
Deadline: July 15

PRCRP Career Development Award
Pre-Application Deadline: July 16
Application Deadline: October 22

PRCRP Idea Award with Special Focus
Pre-Application Deadline: July 16
Application Deadline: October 22

American Cancer Society Clinical Research Professor
LOI Deadline: August 1
Application Deadline: October 15

Mesothelioma Applied Research Foundation Research Grant Funding
Deadline: August 2

American Gastroenterological Association Funderburg Research Award in Gastric Cancer
Deadline: August 30

Translational Technology Concept Studies of Circulating Tumor and Endothelial Cells (CTC/CEC)
Deadline: Open

AACR Scholar-in-Training Awards - Other Conferences and Meetings
Deadline: Open

Case CCC Protocol Specific Research Support (PSRS)
Deadline: Open

International Union Against Cancer (UICC) International Cancer Technology Transfer Fellowships
Application Deadline: Open

International Waldenstrom's Macroglobulinemia Foundation (IWMF) Research Grant Program
Application Deadline: Open

SAIC-Frederick Support of the Cancer Genome Atlas Program
Application Deadline: Open

Solving Kids' Cancer Therapeutic Development Initiative
Application Deadline: Open


NIH BULLETIN – Notices and Funding Opportunities

Identifying Non-coding RNA Targets for Early Detection of Cancer (R01)(PA-12-213)

Quantitative Imaging for Evaluation of Responses to Cancer Therapies (U01)(PAR-11-150)

Research on Malignancies in the Context of HIV/AIDS (R01)(PA-10-290)

Research on Malignancies in the Context of HIV/AIDS (R21)(PA-10-291)

Produced by:
Gillian Irwin Todd
11100 Euclid Avenue, Wearn 149
Cleveland, Ohio 44106-5065
216.844.8317 phone
216.844.7832 fax
gillian.irwin@case.edu

HELP US HELP YOU!

If you have a new grant, recently won an award, or have other newsworthy items, please let us know so we can publicize them in the newsletter and other media outlets. You deserve the accolades!

Send items to gillian.irwin@case.edu.